Body Distribution of Free, Liposomal and Nanoparticle-Associated Mitoxantrone in B16-Melanoma-Bearing Mice
- 4 January 2025
- journal article
- Published by Elsevier in The Journal of Pharmacology and Experimental Therapeutics
- Vol. 280 (1) , 232-237
- https://doi.org/10.1016/s0022-3565(24)36380-3
Abstract
No abstract availableThis publication has 17 references indexed in Scilit:
- Phase I clinical trial and pharmacokinetic evaluation of doxorubicin carried by polyisohexylcyanoacrylate nanoparticlesInvestigational New Drugs, 1992
- Tissue distribution of doxorubicin associated with polyisohexylcyanoacrylate nanoparticlesCancer Chemotherapy and Pharmacology, 1990
- Membrane lipid alteration: Effect on cellular uptake of mitoxantroneLipids, 1988
- The organ distribution and circulation time of intravenously injected colloidal carriers sterically stabilized with a blockcopolymer - poloxamine 908Life Sciences, 1987
- Biodistribution of poly(butyl 2-cyanoacrylate) nanoparticles in rabbitsInternational Journal of Pharmaceutics, 1986
- Ion-paired high-performance liquid chromatographic determination of mitoxantrone in physiological fluidsJournal of Chromatography B: Biomedical Sciences and Applications, 1985
- Molecular and biochemical pharmacology of mitoxantroneCancer Treatment Reviews, 1983
- Mitoxantrone (novantrone): a review of experimental and early clinical studiesCancer Treatment Reviews, 1983
- Toxicity of Polyalkylcyanoacrylate Nanoparticles II: Doxorubicin-Loaded NanoparticlesJournal of Pharmaceutical Sciences, 1982
- Adsorption of Antineoplastic Drugs to Polyalkylcyanoacrylate Nanoparticles and Their Release in Calf SerumJournal of Pharmaceutical Sciences, 1979